Advocacy at a Glance STEVEN GROSSMAN 4/7/17 Advocacy at a Glance STEVEN GROSSMAN 4/7/17 Focus on FDA’s Workplace Needs and more Read More Advocacy at a Glance STEVEN GROSSMAN 3/31/17 Advocacy at a Glance STEVEN GROSSMAN 3/31/17 The FY17 Continuing Resolution Expires Soon and more Read More Advocacy at a Glance STEVEN GROSSMAN 3/24/17 Advocacy at a Glance STEVEN GROSSMAN 3/24/17 President’s Budget Blueprint Puts FDA at Risk and more Read More Advocacy at a Glance STEVEN GROSSMAN 3/17/17 Advocacy at a Glance STEVEN GROSSMAN 3/17/17 Alliance Responds to the President’s Proposals and more Read More Advocacy at a Glance STEVEN GROSSMAN 3/11/17 Advocacy at a Glance STEVEN GROSSMAN 3/11/17 Trump to Release Outline of His Budget Requests and more Read More Advocacy at a Glance STEVEN GROSSMAN 3/3/17 Advocacy at a Glance STEVEN GROSSMAN 3/3/17 FDA Stakeholders Should Be Very Concerned, But Not Panicked Read More Advocacy at a Glance STEVEN GROSSMAN 2/24/17 Advocacy at a Glance STEVEN GROSSMAN 2/24/17 HHS Secretary Price Tours FDA and more Read More Advocacy at a Glance STEVEN GROSSMAN 2/18/17 Advocacy at a Glance STEVEN GROSSMAN 2/18/17 Uncertain Effects on FDA of Hiring Freeze and more Read More Advocacy at a Glance STEVEN GROSSMAN 2/13/17 Advocacy at a Glance STEVEN GROSSMAN 2/13/17 FDA’s Status Uncertain Read More Advocacy at a Glance STEVEN GROSSMAN 2/3/17 Advocacy at a Glance STEVEN GROSSMAN 2/3/17 OMB Clarifies Some Details on the President’s Federal Hiring Freeze and more Read More Advocacy at a Glance STEVEN GROSSMAN 1/27/17 Advocacy at a Glance STEVEN GROSSMAN 1/27/17 Trump Era Begins at HHS and FDA and more Read More Advocacy at a Glance STEVEN GROSSMAN 1/19/17 Advocacy at a Glance STEVEN GROSSMAN 1/19/17 Prepping for the New Congress: Macro- and Micro-Budget Considerations for FDA and more Read More Advocacy at a Glance STEVEN GROSSMAN 1/13/17 Advocacy at a Glance STEVEN GROSSMAN 1/13/17 Sequester May Follow April 28 Expiration of FY 17 CR Read More Advocacy at a Glance STEVEN GROSSMAN 1/6/17 Advocacy at a Glance STEVEN GROSSMAN 1/6/17 Wishing Everyone a Happy and Healthy New Year. Read More Advocacy at a Glance STEVEN GROSSMAN 12/16/16 Advocacy at a Glance STEVEN GROSSMAN 12/16/16 FY 17 Continuing Resolution to Run Through April 28, 2017 Read More Advocacy at a Glance STEVEN GROSSMAN 12/9/16 Advocacy at a Glance STEVEN GROSSMAN 12/9/16 Continuing Resolution Close, But May Not Make Friday Night Deadline Read More Advocacy at a Glance STEVEN GROSSMAN 12/5/16 Advocacy at a Glance STEVEN GROSSMAN 12/5/16 21st Century Cures Passes House; Set for Senate Vote Next Week Read More Advocacy at a Glance STEVEN GROSSMAN 11/21/16 Advocacy at a Glance STEVEN GROSSMAN 11/21/16 Short-Term Continuing Resolution Likely Read More Advocacy at a Glance STEVEN GROSSMAN 11/11/16 Advocacy at a Glance STEVEN GROSSMAN 11/11/16 Mr. Trump, the Election and FDA Read More Advocacy at a Glance STEVEN GROSSMAN 11/7/16 Advocacy at a Glance STEVEN GROSSMAN 11/7/16 FDA and the Elections: Many Unknowns Read More Newer Posts Older Posts
Advocacy at a Glance STEVEN GROSSMAN 4/7/17 Advocacy at a Glance STEVEN GROSSMAN 4/7/17 Focus on FDA’s Workplace Needs and more Read More
Advocacy at a Glance STEVEN GROSSMAN 3/31/17 Advocacy at a Glance STEVEN GROSSMAN 3/31/17 The FY17 Continuing Resolution Expires Soon and more Read More
Advocacy at a Glance STEVEN GROSSMAN 3/24/17 Advocacy at a Glance STEVEN GROSSMAN 3/24/17 President’s Budget Blueprint Puts FDA at Risk and more Read More
Advocacy at a Glance STEVEN GROSSMAN 3/17/17 Advocacy at a Glance STEVEN GROSSMAN 3/17/17 Alliance Responds to the President’s Proposals and more Read More
Advocacy at a Glance STEVEN GROSSMAN 3/11/17 Advocacy at a Glance STEVEN GROSSMAN 3/11/17 Trump to Release Outline of His Budget Requests and more Read More
Advocacy at a Glance STEVEN GROSSMAN 3/3/17 Advocacy at a Glance STEVEN GROSSMAN 3/3/17 FDA Stakeholders Should Be Very Concerned, But Not Panicked Read More
Advocacy at a Glance STEVEN GROSSMAN 2/24/17 Advocacy at a Glance STEVEN GROSSMAN 2/24/17 HHS Secretary Price Tours FDA and more Read More
Advocacy at a Glance STEVEN GROSSMAN 2/18/17 Advocacy at a Glance STEVEN GROSSMAN 2/18/17 Uncertain Effects on FDA of Hiring Freeze and more Read More
Advocacy at a Glance STEVEN GROSSMAN 2/13/17 Advocacy at a Glance STEVEN GROSSMAN 2/13/17 FDA’s Status Uncertain Read More
Advocacy at a Glance STEVEN GROSSMAN 2/3/17 Advocacy at a Glance STEVEN GROSSMAN 2/3/17 OMB Clarifies Some Details on the President’s Federal Hiring Freeze and more Read More
Advocacy at a Glance STEVEN GROSSMAN 1/27/17 Advocacy at a Glance STEVEN GROSSMAN 1/27/17 Trump Era Begins at HHS and FDA and more Read More
Advocacy at a Glance STEVEN GROSSMAN 1/19/17 Advocacy at a Glance STEVEN GROSSMAN 1/19/17 Prepping for the New Congress: Macro- and Micro-Budget Considerations for FDA and more Read More
Advocacy at a Glance STEVEN GROSSMAN 1/13/17 Advocacy at a Glance STEVEN GROSSMAN 1/13/17 Sequester May Follow April 28 Expiration of FY 17 CR Read More
Advocacy at a Glance STEVEN GROSSMAN 1/6/17 Advocacy at a Glance STEVEN GROSSMAN 1/6/17 Wishing Everyone a Happy and Healthy New Year. Read More
Advocacy at a Glance STEVEN GROSSMAN 12/16/16 Advocacy at a Glance STEVEN GROSSMAN 12/16/16 FY 17 Continuing Resolution to Run Through April 28, 2017 Read More
Advocacy at a Glance STEVEN GROSSMAN 12/9/16 Advocacy at a Glance STEVEN GROSSMAN 12/9/16 Continuing Resolution Close, But May Not Make Friday Night Deadline Read More
Advocacy at a Glance STEVEN GROSSMAN 12/5/16 Advocacy at a Glance STEVEN GROSSMAN 12/5/16 21st Century Cures Passes House; Set for Senate Vote Next Week Read More
Advocacy at a Glance STEVEN GROSSMAN 11/21/16 Advocacy at a Glance STEVEN GROSSMAN 11/21/16 Short-Term Continuing Resolution Likely Read More
Advocacy at a Glance STEVEN GROSSMAN 11/11/16 Advocacy at a Glance STEVEN GROSSMAN 11/11/16 Mr. Trump, the Election and FDA Read More
Advocacy at a Glance STEVEN GROSSMAN 11/7/16 Advocacy at a Glance STEVEN GROSSMAN 11/7/16 FDA and the Elections: Many Unknowns Read More
